{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T09:20:13Z","timestamp":1788081613960,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.hoc.2019.01.010","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T06:17:54Z","timestamp":1556173074000},"page":"425-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["von Willebrand Disease in Pediatrics"],"prefix":"10.1016","volume":"33","author":[{"given":"Sarah H.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hoc.2019.01.010_bib1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/hae.12243","article-title":"Erik von Willebrand","volume":"19","author":"Lassila","year":"2013","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.hoc.2019.01.010_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2019.01.010_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.hoc.2019.01.010_bib4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.13749","article-title":"Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice","volume":"15","author":"Swystun","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2019.01.010_bib5","first-page":"94","article-title":"Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2019.01.010_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0038-1647491","article-title":"Bleeding\/bruising symptomatology in children with and without bleeding disorders","volume":"65","author":"Nosek-Cenkowska","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2019.01.010_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"11","key":"10.1016\/j.hoc.2019.01.010_bib8","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1538-7836.2012.04923.x","article-title":"The evolution and value of bleeding assessment tools","volume":"10","author":"Rydz","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2019.01.010_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2011.04265.x","article-title":"Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation","volume":"9","author":"Tosetto","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hoc.2019.01.010_bib10","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2019.01.010_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A\u00a0quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2019.01.010_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2006.04.002","article-title":"Assessing bleeding in von Willebrand disease with bleeding score","volume":"21","author":"Tosetto","year":"2007","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.hoc.2019.01.010_bib13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1538-7836.2010.03796.x","article-title":"Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire","volume":"8","author":"Biss","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"10.1016\/j.hoc.2019.01.010_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26588","article-title":"Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease","volume":"64","author":"Casey","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2019.01.010_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/hae.12653","article-title":"Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'real-world' experience","volume":"21","author":"Ardillon","year":"2015","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.hoc.2019.01.010_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A\u00a0two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.hoc.2019.01.010_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"10.1016\/j.hoc.2019.01.010_bib18","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jth.14145","article-title":"A\u00a0comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients","volume":"16","author":"Vangenechten","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2019.01.010_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2002-27821","article-title":"Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey","volume":"28","author":"Favaloro","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.hoc.2019.01.010_bib20","first-page":"1009","article-title":"Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease","volume":"104","author":"Favaloro","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2019.01.010_bib21","series-title":"Hemostasis and Thrombosis: Methods and Protocols","first-page":"461","article-title":"Laboratory testing for von Willebrand factor: factor VIII binding (for 2N VWD)","author":"Mohammed","year":"2017"},{"issue":"1","key":"10.1016\/j.hoc.2019.01.010_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.hoc.2019.01.010_bib23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2019.01.010_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jth.12927","article-title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease","volume":"13","author":"Sanders","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2019.01.010_bib25","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2019.01.010_bib26","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A\u00a0shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2019.01.010_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2141.2000.01830.x","article-title":"Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history","volume":"108","author":"Nitu-Whalley","year":"2000","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2019.01.010_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1537-1891(02)00304-X","article-title":"Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment","volume":"39","author":"Kluft","year":"2002","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"10.1016\/j.hoc.2019.01.010_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.hoc.2019.01.010_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.thromres.2014.11.007","article-title":"Combined oral contraceptives do not influence von Willebrand factor related biomarkers despite an induced acute phase response","volume":"135","author":"Larsen","year":"2015","journal-title":"Thromb Res"},{"issue":"18","key":"10.1016\/j.hoc.2019.01.010_bib31","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2012-12-471672","article-title":"No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation","volume":"121","author":"Flood","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2019.01.010_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/hae.13396","article-title":"Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease","volume":"24","author":"Favaloro","year":"2018","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.hoc.2019.01.010_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1538-7836.2005.01245.x","article-title":"Provisional criteria for the diagnosis of VWD type 1","volume":"3","author":"Sadler","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2019.01.010_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.hoc.2019.01.010_bib35","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/blood.V128.22.2577.2577","article-title":"No association between normalization of VWF levels and bleeding phenotype in patients with type 1 VWD - from the WiN study","volume":"128","author":"Boender","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2019.01.010_bib36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease","volume":"19","author":"Larsen","year":"2013","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.hoc.2019.01.010_bib37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.13742","article-title":"Clinical and laboratory phenotype variability in type 2M von Willebrand disease","volume":"15","author":"Doruelo","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"19","key":"10.1016\/j.hoc.2019.01.010_bib38","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.hoc.2019.01.010_bib39","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2019.01.010_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","author":"Sadler","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6 Suppl","key":"10.1016\/j.hoc.2019.01.010_bib41","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpag.2010.08.005","article-title":"von Willebrand disease in the pediatric and adolescent population","volume":"23","author":"Mikhail","year":"2010","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"issue":"7","key":"10.1016\/j.hoc.2019.01.010_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2019.01.010_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpag.2009.11.008","article-title":"Menorrhagia in adolescents with inherited bleeding disorders","volume":"23","author":"Chi","year":"2010","journal-title":"Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.hoc.2019.01.010_bib44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpag.2014.12.012","article-title":"Oral tranexamic acid versus combined oral contraceptives for adolescent heavy menstrual bleeding: a pilot study","volume":"28","author":"Srivaths","year":"2015","journal-title":"Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.hoc.2019.01.010_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpag.2019.01.009","article-title":"An open-label, single-arm, efficacy study of tranexamic acid in adolescents with heavy menstrual bleeding","author":"O\u2019Brien","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2019.01.010_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jth.14313","article-title":"Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery","volume":"17","author":"Peyvandi","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.hoc.2019.01.010_bib47","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.12995","article-title":"Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network","volume":"13","author":"Abshire","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2019.01.010_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman","year":"2013","journal-title":"Haematologica"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819300267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819300267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:11:49Z","timestamp":1760184709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858819300267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0889858819300267"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2019.01.010","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand Disease in Pediatrics","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2019.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}